Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Statins and cancer--beyond the "one drug, one disease" model.

Hawk E, Viner JL.

N Engl J Med. 2005 May 26;352(21):2238-9. No abstract available.

PMID:
15917390
2.

[Which indications for statins besides their cholesterol-lowering effect?].

Scheen AJ, Sadzot B.

Rev Med Suisse. 2005 Aug 24;1(30):1954, 1956-9. Review. French.

PMID:
16200939
3.

Current data with HMG-CoA reductase inhibitors (statins) for colorectal cancer prevention.

Tyagi P.

Clin Colorectal Cancer. 2005 Nov;5(4):245-6. Review. No abstract available.

PMID:
16356301
4.

Statins and the risk of colorectal cancer.

Welch HG.

N Engl J Med. 2005 Sep 1;353(9):952-4; author reply 952-4. No abstract available.

PMID:
16136710
5.

Statins and the risk of colorectal cancer.

Setoguchi S, Avorn J, Schneeweiss S.

N Engl J Med. 2005 Sep 1;353(9):952-4; author reply 952-4. No abstract available.

6.

Statins and the risk of colorectal cancer.

Maisonneuve P, Lowenfels AB.

N Engl J Med. 2005 Sep 1;353(9):952-4; author reply 952-4. No abstract available.

PMID:
16136711
7.

Statins and cancer risk: decrease or increase?

Goldstein MR, Mascitelli L, Pezzetta F.

Am J Med. 2008 Sep;121(9):e17, author reply e19. doi: 10.1016/j.amjmed.2008.04.019. No abstract available.

PMID:
18724946
8.

Statins and cancer prevention.

Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM.

Nat Rev Cancer. 2005 Dec;5(12):930-42. Review.

PMID:
16341084
9.

[Statins for the prevention of colorectal carcinoma: not yet recommended].

Koornstra JJ, Kleibeuker JH.

Ned Tijdschr Geneeskd. 2005 Oct 22;149(43):2388-91. Dutch.

PMID:
16277127
10.

Statins and the risk of colorectal cancer.

Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G.

N Engl J Med. 2005 May 26;352(21):2184-92.

11.

Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.

Bonovas S, Filioussi K, Flordellis CS, Sitaras NM.

J Clin Oncol. 2007 Aug 10;25(23):3462-8.

12.

Can statins pass the aspirin litmus test in cancer?

Kauh J, Khuri FR.

J Clin Oncol. 2007 Aug 10;25(23):3395-6. No abstract available.

13.

Statins and the colorectum: hope for chemoprevention?

Baron JA.

Cancer Prev Res (Phila). 2010 May;3(5):573-5. doi: 10.1158/1940-6207.CAPR-10-0050. Epub 2010 Apr 19. Review.

14.

Pleiotropic effects of HMG-CoA reductase inhibitors.

Werner N, Nickenig G, Laufs U.

Basic Res Cardiol. 2002 Mar;97(2):105-16. Review.

PMID:
12002257
15.

Statins and cancer in gastroenterology: new insight?

Gazzerro P, Bifulco M.

Gastroenterology. 2013 Jun;144(7):1572-3. doi: 10.1053/j.gastro.2013.03.055. Epub 2013 Apr 28. No abstract available.

PMID:
23628277
16.

Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.

Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF.

Gastroenterology. 2007 Aug;133(2):393-402. Epub 2007 May 21.

PMID:
17681160
17.

Primary prevention of cardiovascular disease with statins: cautionary notes.

Goldstein MR, Mascitelli L, Pezzetta F.

QJM. 2009 Nov;102(11):817-20. doi: 10.1093/qjmed/hcp099. Epub 2009 Jul 20. No abstract available.

18.

[The statins].

Taurand P.

Soins. 1997 May;(615):53-4. French. No abstract available.

PMID:
9239101
19.

Editorial: Colorectal cancer and statins: reflections from the end of the road.

Ahnen DJ, Byers T.

Am J Gastroenterol. 2009 Dec;104(12):3024-6. doi: 10.1038/ajg.2009.572.

PMID:
19956119
20.

A general assessment of the safety of HMG CoA reductase inhibitors (statins).

Black DM.

Curr Atheroscler Rep. 2002 Jan;4(1):34-41. Review.

PMID:
11772420
Items per page

Supplemental Content

Write to the Help Desk